Mark Deboer is an Endocrinology/Metabolic physician affiliated with University of Virginia. OpenAlex indexes 248 publications with 11,432 citations (h-index 59); ClinicalTrials.gov lists 7 registered studies matched to this name. By OpenAlex citation count, this profile ranks in the top 10% of Pediatric Endocrinology profiles in the findmyKOL directory.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
1204 W Main St
Charlottesville, VA 229032824
Telephone
434-924-0123Provider last certified this registry record 9 Aug 2023.
Clinical trials
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
2 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- SANOFI-AVENTIS U.S. LLCProgram year20251 payment
- Tandem Diabetes Care, Inc.Program year20251 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
NIH funding
7 NIH research awards on record, funded 2008–2026 per NIH RePORTER. The latest:
- Limiting Dysglycemia Around Physical Activity for People with Type 1 Diabetes Using Activity-Aware Automated Insulin Delivery – the APEX Project.
University of Virginia
FY2026$660,262R01DK139065 - Limiting Dysglycemia Around Physical Activity for People with Type 1 Diabetes Using Activity-Aware Automated Insulin Delivery – the APEX Project.
University of Virginia
FY2025$673,151R01DK139065 - Limiting Dysglycemia Around Physical Activity for People with Type 1 Diabetes Using Activity-Aware Automated Insulin Delivery – the APEX Project.
University of Virginia
FY2024$686,100R01DK139065
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Trial of Hybrid Closed-Loop Control in Young Children with Type 1 Diabetes
New England Journal of Medicine
2023 - The Impact of Insulin Resistance on Loss of Lung Function and Response to Treatment in Asthma
American Journal of Respiratory and Critical Care Medicine
2022 - Health-Related Quality of Life and Treatment Satisfaction in Parents and Children with Type 1 Diabetes Using Closed-Loop Control
Diabetes Technology & Therapeutics
2021 - A Randomized Trial of Closed-Loop Control in Children with Type 1 Diabetes
New England Journal of Medicine
2020
Similar KOLs
Other experts from the same institution or the same specialty.
Charles Landen, MD
University of Virginia
Stephen Caldwell
University of Virginia
James Platts-Mills, MD
University of Virginia
Eric Houpt
University of Virginia
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”